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The diagnosis of severe acute respiratory coronavirus 2 (SARS-CoV-2) infection is based on real-time reverse 
transcriptase polymerase reaction (RT-PCR) virus posi-
tivity on nasopharyngeal swab (1). The Society of Tho-
racic Radiology/Radiological Society of North America 
(STR/RSNA) and Prokop et al (2,3) introduced two 
distinct COVID-19 CT probability scores, here labeled 
STR/RSNA and COVID-19 Reporting and Data System 
(CO-RADS). Studies frequently use a single RT-PCR 
with nasopharyngeal swab as the standard of reference 
compared with CT (4,5). To our knowledge, no prior 
study used the more sensitive bronchoalveolar lavage 
(BAL) as a reference standard for comparison to CT for 
the diagnosis of COVID-19 infection.
We evaluated the association of STR/RSNA and CO-
RADS CT probability scores with BAL results in patients 
with two negative nasopharyngeal swab RT-PCR tests.
Materials and Methods
We conducted a retrospective single-center study ap-
proved by the institutional committee on human research 
(protocol number, CE 97/20). Patients included in the 
current study are part of a previously published study (6). 
We included all the consecutive patients from March 16 
to May 19, 2020, who underwent a chest CT scan after 
two consecutive negative nasopharyngeal swabs and fol-
lowed by bronchoscopy with BAL with RT-PCR testing 
for SARS-CoV-2 RNA. RT-PCR testing was performed 
with nasopharyngeal swabs (Xpert [Cepheid] or eNAT 
[Copan Diagnostics]); the viral RNA was extracted, 
amplified, and detected (GeneFinder; Osang Health-
care). For each patient demographic, clinical and labo-
ratory data were recorded. Information obtained from 
the bronchoscopy were noted, as well as the main chest 
CT features (Fig). This research letter differs from the 
previous article (6) for methodologic evaluation of CT 
scans: In particular, each patient’s CT scan was evaluated 
in consensus by two expert radiologists (Z.F., A.P.) and 
for each case, the likelihood of COVID-19 pneumonia 
was reported based on STR/RSNA and CO-RADS stan-
dards (2,3). The two readers acquired their COVID-19 
experience by participating in a previous study (4) where 
they reviewed in consensus 773 CT images in patients 
suspected of having SARS-CoV-2 infection.
Results
We included 46 patients; their characteristics, BAL 
results, and CT findings are described in the Table. 
SARS-CoV-2 was isolated in 18 patients (39%). By 
using STR/RSNA guidelines, 15 of 46 (32%) patients 
were classified as having typical COVID-19 patterns, 
11 of 46 (24%) as having indeterminate patterns, and 
17 of 46 (37%) as having atypical patterns, while three 
of 46 (6.5%) CT scans were negative for pneumonia. 
By using CO-RADS guidelines, very high and high 
levels of suspicion of COVID-19 pneumonia were 
present in 11 of 46 (24%) and 11 of 46 (24%), re-
spectively. Seventeen of 46 other patients (37%) were 
classified as low or very low levels of suspicion. We 
found a positive association between the two scoring 
system (P , .001). The STR/RSNA and CO-RADS 
classification systems were positively associated with 
the presence of SARS-CoV-2 on BAL (P = .006 and P 
= .03, respectively).
The STR/RSNA typical pattern had a sensitivity of 
61% (95% CI: 36, 83), a specificity of 86% (95% CI: 
67, 96), and a positive predictive value of 73% (95% 
CI: 51, 88). Atypical and negative patterns in our small 
population showed a negative predictive value of 82% 
(95% CI: 59, 96) and 100%, respectively.
For CO-RADS score, we consider a score greater 
than or equal to 4 as positive for COVID-19 and a score 
less than or equal to 3 as negative: The sensitivity, speci-
ficity, positive predictive value, and negative predictive 
value were 72% (95% CI: 46, 90), 68% (95% CI: 48, 
84), 59% (95% CI: 44, 73), and 79% (95% CI: 63, 
89).
BAL was able to identify the presence of SARS-CoV-2 
RNA in 10 of 11 patients with both a typical STR/RSNA 
pattern and a white blood cell count less than 11 000 
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Discussion
The majority of studies evaluating the accuracy of CT in the 
diagnosis of coronavirus disease 2019 (COVID-19) used a 
single nasopharyngeal reverse transcriptase polymerase reac-
tion (RT-PCR) as reference standard and a minority used 
multiple RT-PCR tests (4,5). Our results seem to confirm 
the hypothesis that the diagnosis of COVID-19 should not 
rely exclusively on the RT-PCR testing. In our cohort, the 
integration of clinical, radiologic, and bronchoalveolar la-
vage results led us to a definitive diagnosis in 78% of pa-
tients (36 of 46). Society of Thoracic Radiology/Radiologi-
cal Society of North America (STR/RSNA) and COVID-19 
Reporting and Data System (CO-RADS) diagnostic accu-
racies were evaluated: Sensitivity, specificity, and positive 
predictive value were slightly lower than those described by 
previous studies (4,5). We believe that this difference is due 
to a smaller population and the requirement for two con-
secutive negative nasopharyngeal swabs with the presence of 
continued symptoms.
We found the association of a typical STR/RSNA pattern or 
a CO-RADS 5 and a normal white blood cell count extremely 
Abbreviations
BAL = bronchoalveolar lavage, CO-RADS = COVID-19 Reporting 
and Data System, COVID-19 = coronavirus disease 2019, RT-PCR = 
reverse transcriptase polymerase reaction, SARS-CoV-2 = severe acute 
respiratory coronavirus 2, STR/RSNA = Society of Thoracic Radiology/
Radiological Society of North America
Summary
In patients suspected of having coronavirus disease 2019 
(COVID-19) who have two consecutive negative nasopharyngeal 
swab tests, high-probability CT infection measured with Society 
of Thoracic Radiology/Radiological Society of North America and 
COVID-19 Reporting and Data System scores were associated with 
bronchoalveolar lavage findings.
cells/µL (P = .005) and in seven of eight patients with both 
a CO-RADS 5 classification and a normal white blood cell 
count (P = .03).
The areas under the receiver operating characteristic curve 
were similar for STR/RSNA and CO-RADS (0.79 [95% CI: 
0.66, 0.92]) and 0.78 [95% CI: 0.64, 0.91]); P = .67 for the 
comparison).
Images show chest CT features of patients with true-positive and false-positive results. A, In a 60-year-old man with bilateral diffuse areas of 
consolidation associated with ground-glass opacity (GGO), chest CT was classified as coronavirus disease 2019 (COVID-19) Reporting 
and Data System (CO-RADS) category 5 and as typical with Society of Thoracic Radiology/Radiological Society of North America (STR/
RSNA) probability score, with subsequent confirmed diagnosis of COVID-19 based on fluid obtained at bronchoalveolar lavage (BAL). B, 
In a 54-year-old man with bilateral peripheral patchy areas of GGO who was hospitalized but not treated for COVID-19, an alternative 
diagnosis of viral pneumonia due to metapneumovirus was determined after BAL. Chest CT was classified as CO-RADS category 4 and as 
indeterminate with STR/RSNA probability score. 
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Demographics and Patients’ Characteristics
Variable
All  
(n = 46) (%)
Nonidentified  
SARS-CoV-2  
(n = 28) (%)
Identified  
SARS-CoV-2  
(n = 18) (%) P Value
Sex
 Female 15 (31) 9 (32) 6 (33) .93
 Male 31 (67) 19 (68) 12 (67)
Age (y)
 ,65 27 (59) 14 (50) 13 (72) .15
 65–75 10 (21) 6 (21) 4 (22)
 .75 9 (21) 8 (29) 1 (5.56)
 Median* 60 (50–72) 65 (52–79) 55 (47–71) .15
Hospital unit
 Internistic ward 31 (67) 21 (75) 10 (56) .37
 Subintensive care 10 (22) 5 (18) 5 (28)
 Other 5 (11) 2 (7.1) 3 (17)
Indication for bronchoscopy
 Suspected SARS-CoV-2 infection 27 (59) 11 (39) 16 (89) .003
 Suspected superinfection 12 (26) 10 (36) 2 (11)
 Alternative diagnosis 7 (15) 7 (25) 0 (0)
Symptoms
 No 7 (15) 7 (25) 0 (0) .03
 Yes 39 (85) 21 (75) 20 (100)
Days from symptoms’ onset to bronchoscopy (n = 41)
 Median* 14 (7–23) 15 (7–31) 12 (7–19) .52
Days from nasopharyngeal swab to bronchoscopy (n = 41)
 Median* 1.00 (1–3) 1 (1–3) 2 (1–4.5) .69
White blood cell count (3103/µL)
 Median* 6.8 (5.6–9.6) 7.0 (5.5–9.8) 6.2 (5.8–8.9) .78
C-reactive protein (mg/dL)
 Median* 7.3 (1.5–12.8) 5.1 (0.9–14.0) 7.9 (4.1–10.8) .57
Procalcitonin (ng/mL)
 Median* 0.10 (0.05–0.21) 0.09 (0.05–0.55) 0.10 (0.05–0.16) .70
No. of CT pattern alterations per patient†
 Median* 5 (4–7) 5 (3.5–6) 6 (5–7) .03
STR/RSNA
 Negative for pneumonia 3 3 (100) 0 (0) .005
 Atypical appearance 17 14 (82) 3 (18)
 Indeterminate appearance 11 7 (64) 4 (36)
 Typical appearance 15 4 (27) 11 (73)
CO-RADS
 Very lower level of suspicion, 1 3 3 (100) 0 (0) .03
 Low level of suspicion, 2 14 12 (86) 2 (14)
 Equivocal findings, 3 7 4 (57) 3 (43)
 High level of suspicion, 4 11 6 (55) 5 (45)
 Very high level of suspicion, 5 11 3 (27) 8 (73)
Note.—Unless otherwise specified, data are numbers, with percentages in parentheses. CO-RADS = Coronavirus Disease 2019 Reporting 
and Data System, SARS-CoV-2 = severe acute respiratory coronavirus 2, STR/RSNA = Society of Thoracic Radiology/Radiological Society 
of North America.
* Data are medians, with interquartile ranges in parentheses.
† CT alteration patterns: bilateral, peripheral, posterior, multilobar involvement, presence of ground-glass opacities, consolidations, crazy 
paving, reversed halo sign, pericardial effusion, lymph node enlargements.
specific in identifying uncomplicated SARS-CoV-2 infection. 
This association may help the clinician distinguishing between 
COVID-19 and an interstitial pneumonia with bacterial etiology, 
and it could be used as the additional step as a proxy for BAL.
In conclusion, the integration of bronchoalveolar lavage in 
diagnostic flowchart in patients with two consecutive nega-
tive reverse transcriptase polymerase reaction nasopharyn-
geal swabs could lead a diagnosis in almost 80% of patients; 
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typical and/or high-suspicion CT pattern, as well as white 
blood cell count, could orientate decision to perform other 
invasive testing. Further research will be needed to validate 
our findings.
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